← Browse by Condition
Medical Condition

small cell lung cancer extensive stage

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 1, Phase 2
NCT06739928 Phase 2
Recruiting

Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC

Enrollment
120 pts
Location
China
Sponsor
Guangzhou Institute of Respira...
View Trial →
NCT05703971 Phase 1, Phase 2
Recruiting

Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

Enrollment
62 pts
Location
United States
Sponsor
Genprex, Inc.
View Trial →
NCT05384015 Phase 2
Recruiting

Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer

Enrollment
46 pts
Location
Spain
Sponsor
Fundación GECP
View Trial →